Eun Sook Park

Title: Eun Sook Park: Innovator in Influenza Virus Detection

Introduction

Eun Sook Park is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of virology, particularly in the detection of highly pathogenic influenza viruses. Her innovative work has led to the development of a patented marker that enhances the detection and treatment of influenza A virus.

Latest Patents

Eun Sook Park holds a patent for a "Marker for detecting highly pathogenic influenza virus and use thereof." This patent includes a protein mutant prepared by substituting the amino acids 68 and 69 of a PB1-F2 protein. The invention provides a composition for detecting a highly pathogenic virus, which includes an agent for measuring the protein mutant. Additionally, it features a detection kit and a method for detecting the virus by measuring the protein mutant. The patent also encompasses an antiviral composition against the influenza A virus, which includes an inhibitor of binding between the modified PB1-F2 protein and DDX3, along with a method for screening antiviral substances against the influenza A virus. Eun Sook Park has 1 patent to her name.

Career Highlights

Eun Sook Park is currently associated with Dandi Bioscience Inc., where she continues her research and development efforts. Her work is pivotal in advancing the understanding and management of influenza viruses, contributing to public health and safety.

Collaborations

Eun Sook Park collaborates with notable colleagues, including Kyun-Hwan Kim and Yeong-Min Park. Their combined expertise enhances the research and development initiatives at Dandi Bioscience Inc.

Conclusion

Eun Sook Park's innovative contributions to the detection of highly pathogenic influenza viruses underscore her importance in the field of virology. Her patented work not only advances scientific knowledge but also has practical implications for public health.